Cargando…

Research into biomarkers to facilitate the early identification of Parkinson's disease: a decision analytic model to determine the feasibility and value

Detalles Bibliográficos
Autores principales:	Hunter, Rachael, Proctor, Gordon, Noyce, Alastair, Schrag, Anette, Ward, Elaine, Galloway, John
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3980695/ http://dx.doi.org/10.1186/1745-6215-14-S1-P52

Ejemplares similares

The prodromes of Parkinson's disease
por: Rees, Richard Nathaniel, et al.
Publicado: (2018)

The prediagnostic phase of Parkinson's disease
por: Noyce, Alastair John, et al.
Publicado: (2016)

Predicting diagnosis of Parkinson's disease: A risk algorithm based on primary care presentations
por: Schrag, Anette, et al.
Publicado: (2019)

An early diagnosis is not the same as a timely diagnosis of Parkinson's disease
por: Rees, Richard Nathaniel, et al.
Publicado: (2018)

Lower Lymphocyte Count is Associated With Increased Risk of Parkinson’s Disease
por: Jensen, Melanie P., et al.
Publicado: (2021)

Meta-Analysis of Early Nonmotor Features and Risk Factors for Parkinson Disease
por: Noyce, Alastair J, et al.
Publicado: (2012)

Testing Shortened Versions of Smell Tests to Screen for Hyposmia in Parkinson's Disease
por: Auger, Stephen D., et al.
Publicado: (2020)

Optimising classification of Parkinson’s disease based on motor, olfactory, neuropsychiatric and sleep features
por: Bestwick, Jonathan P., et al.
Publicado: (2021)

Developing and assessing a new web-based tapping test for measuring distal movement in Parkinson’s disease: a Distal Finger Tapping test
por: Akram, Noreen, et al.
Publicado: (2022)

Improving estimation of Parkinson’s disease risk—the enhanced PREDICT-PD algorithm
por: Bestwick, Jonathan P., et al.
Publicado: (2021)

PREDICT-PD: Identifying risk of Parkinson's disease in the community: methods and baseline results
por: Noyce, Alastair J, et al.
Publicado: (2014)

Domotics, Smart Homes, and Parkinson’s Disease
por: Simonet, Cristina, et al.
Publicado: (2021)

The motor prodromes of parkinson’s disease: from bedside observation to large-scale application
por: Simonet, C., et al.
Publicado: (2019)

Application of a Simple Parkinson's Disease Risk Score in a Longitudinal Population‐Based Cohort
por: Marini, Kathrin, et al.
Publicado: (2020)

Subtle motor disturbances in PREDICT-PD participants
por: Noyce, Alastair J, et al.
Publicado: (2017)

Parkinson’s disease determinants, prediction and gene–environment interactions in the UK Biobank
por: Jacobs, Benjamin Meir, et al.
Publicado: (2020)

Mendelian Randomization — the Key to Understanding Aspects of Parkinson's Disease Causation?
por: Noyce, Alastair J., et al.
Publicado: (2015)

PREDICT‐PD: An online approach to prospectively identify risk indicators of Parkinson's disease
por: Noyce, Alastair J., et al.
Publicado: (2017)

The Validity of Health-Related Quality of Life Instruments in Patients With Late-Stage Parkinson’s Disease
por: Ramadhan, Mouhammed, et al.
Publicado: (2022)

Technologies Assessing Limb Bradykinesia in Parkinson’s Disease
por: Hasan, Hasan, et al.
Publicado: (2017)

Caregiver Burden and Quality of Life in Late Stage Parkinson’s Disease
por: Rosqvist, Kristina, et al.
Publicado: (2022)

Mild Cognitive Impairment in Parkinson’s Disease—What Is It?
por: Weil, Rimona S., et al.
Publicado: (2018)

Infection and Risk of Parkinson’s Disease
por: Smeyne, Richard J., et al.
Publicado: (2021)

The Parkinson’s phenome—traits associated with Parkinson’s disease in a broadly phenotyped cohort
por: Heilbron, Karl, et al.
Publicado: (2019)

Screening performance of abbreviated versions of the UPSIT smell test
por: Joseph, Theresita, et al.
Publicado: (2019)

The experience of Anxiety for people with Parkinson’s disease
por: Blundell, Emma. K., et al.
Publicado: (2023)

The Role of Cognitive-Behavioural Therapy for Patients with Depression in Parkinson's Disease
por: Charidimou, Andreas, et al.
Publicado: (2011)

Transitions and challenges for people with Parkinson’s and their family members: A qualitative study
por: Read, Joy, et al.
Publicado: (2022)

Bidirectional relationship between olfaction and Parkinson’s disease
por: Kim, Jonggeol J., et al.
Publicado: (2023)

Change in the incidence of Parkinson’s disease in a large UK primary care database
por: Okunoye, Olaitan, et al.
Publicado: (2022)

Ethnic Variation in the Manifestation of Parkinson’s Disease: A Narrative Review
por: Ben-Joseph, Aaron, et al.
Publicado: (2020)

Assessing cognitive dysfunction in Parkinson's disease: An online tool to detect visuo‐perceptual deficits
por: Weil, Rimona S., et al.
Publicado: (2018)

Perspectives on Care for Late-Stage Parkinson's Disease
por: Rosqvist, Kristina, et al.
Publicado: (2021)

Dissociable effects of dopaminergic medications on depression symptom dimensions in Parkinson’s disease
por: Costello, Harry, et al.
Publicado: (2023)

The Association Between Type 2 Diabetes Mellitus and Parkinson’s Disease
por: Cheong, Julia L.Y., et al.
Publicado: (2020)

Health care professionals’ perspectives on self-management for people with Parkinson’s: qualitative findings from a UK study
por: Armstrong, Megan, et al.
Publicado: (2021)

Adolescent and Adult Children of Parents with Parkinson's Disease: Incorporating Their Needs in Clinical Guidelines
por: Morley, David, et al.
Publicado: (2011)

Support Needs in Carers of People With Parkinson’s From Early to Later Stages: A Qualitative Study With 36 Carers in 11 European Countries
por: Merritt, Rowena K., et al.
Publicado: (2023)

Why do patients with Parkinson’s disease fall? A cross-sectional analysis of possible causes of falls
por: Schrag, Anette, et al.
Publicado: (2015)

Evaluating Lipid‐Lowering Drug Targets for Parkinson's Disease Prevention with Mendelian Randomization
por: Williams, Dylan M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_r81j4ctke3jilp7s99eea9qkir